Global Mucosal Atomization Devices Market Report By Product Type (Nasal Atomization Devices, Fibre-Optic Atomization Devices, Laryngo-Tracheal Atomization Devices And Bottle Atomizer Devices), Technology (Gas Propelled Atomization Devices And Electrical Atomization Devices), End-User (Hospitals, Ambulatory Surgical Centers And Specialized Clinics) – Industry Trends and Forecast to 2029
Market Analysis and Size
Mucosal atomization devices or MAD are used for the automized delivery of medicine to the nasal, oral, laryngeal, tracheal and pulmonic mucosal surfaces. It's a needle-free painkiller sending trick, which features less frightening in families. Along with this, product types of mucosal atomization policies include nasal atomization devices, fibre-optic atomization devices, laryngotracheal atomization devices, and flagon atomizer policies.
Data Bridge Market Research analyses that the mucosal atomization devices market which was USD 915.6 million in 2021, would rocket up to USD 1694.71 Million by 2029, and is expected to undergo a CAGR of 8.0% during the forecast period of 2022 to 2029. This indicates that the market value. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Market Definition
Mucosal atomization devices are mainly recycled to deliver drugs through nasal mucosa for treating chronic diseases such as allergic rhinitis and sinusitis. The nasal route is being favorite increasingly by the medical sector as it permits quick fascination of the therapeutics and offers bigger efficiency. The acceptance of mucosal atomization strategies is on the rise as it provides a very dense another to the traditional needle-based vaccination drug delivery method.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2019 - 2014)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (On Casters, Wall Mounted, Table Top, Ceiling Mounted), Price Range (Low-Range, Mid-Range, Premium-Range), Application (Neuro and Spine Surgery, Plastic and Reconstructive Surgery, Ophthalmology, Gynecology and Urology, Oncology, Ear, Nose, and Throat (ENT) Surgery, Dentistry, Documentation), End User (Hospitals, Outpatient Facilities, Ambulatory Centers, Clinics, Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
Teleflex Incorporated (U.S), DeVilbiss Healthcare LLC (U.S), BD (U.S), Kurve Therapeutics (U.S), Cook (U.S), Medica Holdings LLC (U.S)
|
|
Market Opportunities
|
|
Mucosal Atomization Devices Market Dynamics
Drivers
- Growing prevalence of sinusitis
Rise in petition for non-invasive activities, growing acceptance of these atomization devices and scientific progress in these strategies are the main patrons to the growing of the mucosal atomization devices market. The mucosal atomization devices market is also fast power due to factors such as rapid transfer of medicine to the bloodstream, non-invasive flora of these campaigns, no first-pass absorption, and comfort of direction.
- Gas Propelled Segment is the Fastest Growing Segment of the Mucosal Atomization Devices Market
Due to the increased use of gas propelled mucosal atomization devices around the world, the gas propelled segment is growing at a healthy rate. Inflammation awareness about a number of benefits connected with vapour forced mucosal atomization devices, such as effective, safe, easy-to-use, needle-free, and trouble-free devices, is one of the primary reasons driving segment growth.
Opportunities
Technical developments in the healthcare sector is consequential into the launch of new and advanced devices, which is leading to the development of the mucosal atomization devices market. For of the overview of numerous advanced devices, neighboring are numerous welfares of by means of these devices, such as better-quality usability and bioavailability data, which is likely to surge the rate of adoption of these campaigns.
Restraints/Challenges
- The limitations related to the mucosal atomization devices and collective numeral of product remembrances are the topmost influences impeding the growing of the mucosal atomization devices market. The 5.0 – 7.0 is the physiologic pH of nasal mucosa.
- Capsules that do not fall between this pH series may lead to irritation in the nasal mucosa and impact absorption. This also mains to impediment, bleeding, or overcrowding in the nose which may stop the running of the capsule and can diminish the petition for mucosal atomization devices.
This mucosal atomization devices market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the mucosal atomization devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Mucosal Atomization Devices Market
The COVID-19 outbreak has changed the growth projections of frequent sectors and businesses. The analysts at TMR Study have conducted a conscientious survey on the markets after the pandemic struck. The experts have put out their clear and well-researched spirits in the report. The opinions will help the sponsors to plan their strategy accordingly.COVID-19 is significantly impacting the business and international economy in addition to the serious inferences on public health. As the epidemic remains to evolve, there has been a serious need for businesses to reconsideration and reconfigure their working modules for the changed world.
Recent Development
- In October 2021, Pulmodyne Inc. and Alcove Manufacturing and Distribution Inc. entered a partnership to expand distribution, integrate manufacturing, and continue joint development of new atomization technologies.
- In June 2021, Tiziana Life Sciences PLC entered an agreement with FHI Clinical to conduct a Phase 2 Proof-of-Concept study in Brazil to evaluate the safety, tolerability, and efficacy of intranasal Foralumab in hospitalized patients with severe COVID-19 and pulmonary inflammation.
- In October 2021, Alcove Manufacturing and Distribution Inc. and Pulmodyne Inc. have formed a collaboration to expand distribution, consolidate manufacturing, and continue cooperative research of novel atomization technologies.
- In June 2021, Tiziana Life Sciences PLC has signed a Phase 2 Proof-of-Concept agreement with FHI Clinical to assess the safety, tolerability, and efficacy of intranasal Foralumab in hospitalised patients with severe COVID-19 and pulmonary inflammation.
Global Mucosal Atomization Devices Market Scope
The mucosal atomization devices market is segmented on the basis of type, price range, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Nasal Atomization Devices
- Fibre-Optic Atomization Devices
- Laryngo-Tracheal Atomization Devices
- Bottle Atomizer Devices
On the basis of type the market is segmented into Nasal Atomization Devices, Fibre-Optic Atomization Devices, Laryngo-Tracheal Atomization Devices and Bottle Atomizer Devices.
Technology
- Gas Propelled Atomization Devices
- Electrical Atomization Devices
On the basis of type the market is segmented into Gas Propelled Atomization Devices and Electrical Atomization Devices.
End User
- Hospitals
- Ambulatory Surgical Centers
- Specialized Clinics
On the basis of type the market is segmented Hospitals, Ambulatory Surgical Centers and Specialized Clinics.
Mucosal Atomization Devices Market Regional Analysis/Insights
The mucosal atomization devices market is analysed and market size insights and trends are provided by country, type, price range, application and end user as referenced above.
The countries covered in the mucosal atomization devices market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America is expected to dominate the overall market throughout the forecast period. The market growth is due to the factors, such as the company of key players, high occurrence of allergic rhinitis and sinus in the region, and recognized healthcare infrastructure. Additionally, beneficial government initiatives and an increase in the number of research partnerships are some of the drivers expected to increase the market growth.
Asia-Pacific is expected to witness significant growth during the forecast period of 2022 to 2029 due to the increase in government initiatives to promote awareness, rise in medical tourism, growing research activities in the region, availability of massive untapped markets, large population pool, and the growing demand for quality healthcare in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The mucosal atomization devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for mucosal atomization devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the mucosal atomization devices market. The data is available for historic period 2010-2020.
Competitive Landscape and Mucosal Atomization Devices Market Share Analysis
The mucosal atomization devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to mucosal atomization devices market.
Some of the major players operating in the mucosal atomization devices market are:
- Teleflex Incorporated (U.S)
- DeVilbiss Healthcare LLC (U.S)
- BD (U.S)
- Kurve Therapeutics (U.S)
- Cook (U.S)
- Medica Holdings LLC (U.S)
SKU-